HBV RNA Levels and Pregnancy Outcomes in Hepatitis B Carriers
Author Information
Author(s): Manman Zhang, Xin Liao, Heng Wang, Huan Wu, Baofang Zhang
Primary Institution: Affiliated Hospital of Guizhou Medical University
Hypothesis
This study aims to investigate the relationship between hepatitis B virus (HBV) RNA level and pregnancy outcomes among hepatitis B carriers.
Conclusion
The HBV RNA level has a significant negative impact on pregnancy outcomes and may serve as an indicator to guide the prevention of intrahepatic cholestasis of pregnancy (ICP) and improve maternal health.
Supporting Evidence
- 203 out of 562 pregnant women were infected with HBV.
- HBsAg positive pregnant women had a higher risk of intrahepatic cholestasis of pregnancy (ICP).
- Maternal HBV RNA level was identified as an independent risk factor for ICP.
Takeaway
This study found that higher levels of HBV RNA in pregnant women can lead to more complications during pregnancy, like liver issues.
Methodology
The study collected data from pregnant women attending a hospital, measuring HBV RNA, HBV DNA, and various pregnancy outcomes.
Potential Biases
The study's findings may not be generalizable to other populations due to the homogeneity of the sample.
Limitations
The sample size was small, the study population was entirely Chinese, and the methods for measuring HBV RNA are still evolving.
Participant Demographics
The study included 562 pregnant women, with 203 (36.12%) being HBV positive.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI: 2.036~7.142
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website